Filing Details

Accession Number:
0001127602-19-015117
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-04-09 17:10:44
Reporting Period:
2019-04-08
Accepted Time:
2019-04-09 17:10:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
816956 Conmed Corp CNMD Electromedical & Electrotherapeutic Apparatus (3845) 160977505
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1404850 Dirk Kuyper C/O Conmed Corporation
525 French Road
Utica NY 13502
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-04-08 1,000 $33.43 13,906 No 4 M Direct
Common Stock Disposition 2019-04-08 406 $82.38 13,500 No 4 F Direct
Common Stock Acquisiton 2019-04-08 1,000 $39.64 14,500 No 4 M Direct
Common Stock Disposition 2019-04-08 482 $82.38 14,018 No 4 F Direct
Common Stock Acquisiton 2019-04-08 1,000 $55.70 15,018 No 4 M Direct
Common Stock Disposition 2019-04-08 677 $82.38 14,341 No 4 F Direct
Common Stock Disposition 2019-04-08 2,000 $83.39 12,341 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Sars (Stock Appreciation Rights) Disposition 2019-04-08 1,000 $0.00 1,000 $33.43
Common Stock Sars (Stock Appreciation Rights) Disposition 2019-04-08 1,000 $0.00 1,000 $39.64
Common Stock Sars (Stock Appreciation Rights) Disposition 2019-04-08 1,000 $0.00 1,000 $55.70
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2014-06-01 2023-07-26 No 4 M Direct
0 2015-06-01 2024-09-11 No 4 M Direct
0 2016-06-01 2025-06-01 No 4 M Direct
Footnotes
  1. The exercise reported in this Form 4 was effected pursuant to a rule 10b5-1 Trading Plan adopted by the reporting person on March 6, 2019.
  2. The exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on March 6, 2019.
  3. The exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on March 6, 2019.
  4. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on March 6, 2019.
  5. The stock appreciation rights ("SARs") were granted under the Company's 2007 Amended and Restated Non-Employee Director Equity Compensation Plan, with the SARs generally vesting 100% after a one year period.
  6. The stock appreciation rights ("SARs") were granted under the Company's 2007 Amended and Restated Non-Employee Director Equity Compensation Plan, with the SARs generally vesting upon completion of the term of service.